Cannabics Pharmaceuticals Inc. (CNBX) financial statements (2020 and earlier)

Company profile

Business Address #3 BETHESDA METRO CENTER
BETHESDA, MD 20814
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
8/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3193,5221,3943,368192599
Cash and cash equivalents3192661,3943,368192599
Short-term investments 3,256     
Prepaid expense2312842271503014
Advance royalties 500     
Other undisclosed current assets2,490      
Total current assets:3,0414,3071,6213,5172226113
Noncurrent Assets
Property, plant and equipment9611,002974120231
Long-term investments and receivables  590    
Long-term investments  590    
Intangible assets, net (including goodwill), including:      4,410
Other undisclosed intangible assets, net (including goodwill)      4,410
Advance royalties 3,863     
Other undisclosed noncurrent assets2,4606,011     
Total noncurrent assets:3,42110,8761,564120234,411
TOTAL ASSETS:6,46215,1833,1853,63824294,524
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:21721531638726511425
Accrued liabilities     8 
Other undisclosed accounts payable and accrued liabilities21721531638726510625
Derivative instruments and hedges, liabilities   661  
Due to related parties22422422424622422449
Other undisclosed current liabilities   0   
Total current liabilities:44043953969949133874
Noncurrent Liabilities
Total liabilities:44043953969949133874
Stockholders' equity
Stockholders' equity attributable to parent, including:6,02114,7442,6462,939(467)(310)4,450
Common stock13131212111010
Additional paid in capital15,27015,3009,8406,4471,1089595,178
Accumulated other comprehensive income (loss)(741)2,810     
Accumulated deficit(11,306)(6,164)(7,297)(3,520)(1,586)(1,279)(738)
Other additional capital 2,78490    
Warrants and rights outstanding2,784      
Other undisclosed stockholders' equity attributable to parent(0)(0)  0  
Total stockholders' equity:6,02114,7442,6462,939(467)(310)4,450
TOTAL LIABILITIES AND EQUITY:6,46215,1833,1853,63824294,524

Income statement (P&L) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
8/31/2014
Gross profit:810106113  
Operating expenses(3,479)(3,313)(3,818)(1,860)(393)(540)(216)
Other undisclosed operating loss  (0)    
Operating loss:(3,471)(3,304)(3,809)(1,854)(281)(540)(216)
Nonoperating income (expense)2604,579 (69)(28)(2)(3)
Investment income, nonoperating142142     
Other nonoperating income (expense)1184,437 (80)(27)(2)(3)
Interest and debt expense  (1)(4)(7)(3)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(3,211)1,275(3,810)(1,927)(316)(544)(220)
Other undisclosed income from continuing operations before income taxes     31
Income (loss) from continuing operations:(3,211)1,275(3,810)(1,927)(316)(541)(219)
Loss from discontinued operations      (51)
Income (loss) before gain (loss) on sale of properties:(3,211)1,275(3,810)(1,927)(316)(541)(270)
Other undisclosed net income (loss)3,0883,08833(7)   
Net income (loss):(123)4,363(3,777)(1,934)(316)(541)(270)
Other undisclosed net income (loss) attributable to parent(3,230)(3,230)  9  
Net income (loss) available to common stockholders, diluted:(3,353)1,133(3,777)(1,934)(307)(541)(270)

Comprehensive Income ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
8/31/2014
Net income (loss):(123)4,363(3,777)(1,934)(316)(541)(270)
Comprehensive income (loss):(123)4,363(3,777)(1,934)(316)(541)(270)
Other undisclosed comprehensive loss, net of tax, attributable to parent(1,161)(420)     
Comprehensive income (loss), net of tax, attributable to parent:(1,284)3,943(3,777)(1,934)(316)(541)(270)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: